Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.

Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.

Item
http://www.wikidata.org/entity/Q33358828
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cellsDocetaxel in the management of ovarian cancer.SCOTROC 2A: carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer.Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer.Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth.[The action and toxicity of taxanes].Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials.
P2860

Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity.

Item
http://www.wikidata.org/entity/Q33358828
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@ast
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@en
type
label
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@ast
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@en
prefLabel
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@ast
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Docetaxel versus paclitaxel fo ...... -control analysis of toxicity.
@en
P2093
P304
P31
P356
10.1097/01.COC.0000045849.95834.6B
P433
P478
P577
P698
P921